NPI: 1134191836 · ROCKVILLE, MD 20854 · Clinical Social Worker · NPI assigned 02/06/2006
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 02/06/2006 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,024 | $199K |
| 2019 | 12,796 | $392K |
| 2020 | 100,088 | $1.36M |
| 2021 | 270,439 | $5.23M |
| 2022 | 443,659 | $3.82M |
| 2023 | 227,155 | $1.90M |
| 2024 | 134,135 | $1.10M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 352,161 | 258,933 | $5.52M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 122,548 | 91,348 | $1.92M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 29,566 | 24,380 | $1.38M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45,023 | 34,721 | $1.34M |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 90,671 | 73,876 | $902K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 23,393 | 17,868 | $707K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15,838 | 12,799 | $661K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 16,302 | 11,081 | $344K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 15,670 | 13,096 | $160K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2,475 | 2,082 | $160K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5,951 | 4,896 | $155K |
| 86580 | 8,907 | 6,886 | $88K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13,761 | 5,962 | $74K |
| 99401 | 3,349 | 2,790 | $68K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 15,159 | 11,078 | $62K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6,673 | 5,824 | $38K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,194 | 2,189 | $37K |
| 90739 | 699 | 521 | $32K | |
| 90715 | 3,092 | 2,187 | $29K | |
| 90746 | 994 | 659 | $29K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2,004 | 1,606 | $25K |
| 90716 | 850 | 672 | $22K | |
| 90674 | 3,608 | 2,773 | $22K | |
| 90651 | 438 | 293 | $19K | |
| 90686 | 2,552 | 2,071 | $19K | |
| 99201 | 597 | 463 | $13K | |
| 0071A | 495 | 306 | $11K | |
| 0001A | 628 | 392 | $11K | |
| 0081A | 874 | 404 | $10K | |
| 0072A | 393 | 256 | $9K | |
| 0082A | 591 | 352 | $9K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3,751 | 1,953 | $8K |
| 81002 | 5,432 | 4,304 | $8K | |
| 0002A | 372 | 230 | $7K | |
| 0083A | 291 | 229 | $7K | |
| 90707 | 917 | 721 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 771 | 646 | $6K |
| 91320 | 146 | 134 | $6K | |
| 1036F | 75,275 | 55,007 | $6K | |
| 90661 | 203 | 188 | $5K | |
| 81025 | 2,039 | 1,611 | $5K | |
| 90480 | 460 | 390 | $5K | |
| 0004A | 288 | 164 | $5K | |
| 3074F | 66,488 | 50,006 | $4K | |
| 91322 | 183 | 150 | $4K | |
| 90632 | 112 | 74 | $3K | |
| 99402 | 150 | 143 | $3K | |
| 0031A | 67 | 64 | $3K | |
| 0121A | 134 | 121 | $2K | |
| 90713 | 215 | 176 | $2K | |
| 90682 | 185 | 140 | $2K | |
| 90619 | 201 | 137 | $1K | |
| 0124A | 76 | 70 | $1K | |
| 3008F | 64,906 | 49,177 | $1K | |
| 90656 | 102 | 96 | $1K | |
| 90714 | 94 | 82 | $1K | |
| 0052A | 152 | 142 | $1K | |
| 36415 | Collection of venous blood by venipuncture | 1,192 | 894 | $1K |
| 90734 | 122 | 102 | $977.12 | |
| 0154A | 29 | 29 | $849.52 | |
| 0074A | 74 | 36 | $758.57 | |
| 0051A | 128 | 115 | $754.78 | |
| 86328 | 65 | 61 | $636.26 | |
| 0171A | 18 | 17 | $626.91 | |
| 87905 | 135 | 89 | $543.93 | |
| G0008 | Administration of influenza virus vaccine | 95 | 81 | $488.47 |
| 1160F | 49,757 | 41,134 | $443.60 | |
| 91321 | 52 | 52 | $441.12 | |
| 0173A | 17 | 16 | $399.25 | |
| 90700 | 40 | 16 | $310.70 | |
| 1159F | 48,886 | 40,468 | $300.00 | |
| 3078F | 56,898 | 43,043 | $150.00 | |
| 90694 | 17 | 16 | $138.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 37 | 36 | $135.64 |
| 3079F | 12,873 | 9,551 | $125.00 | |
| 86308 | 86 | 60 | $90.83 | |
| 3077F | 2,002 | 1,513 | $75.00 | |
| 3080F | 1,692 | 1,351 | $50.00 | |
| 3075F | 4,614 | 3,300 | $50.00 | |
| 91308 | 1,104 | 818 | $40.01 | |
| 91307 | 295 | 179 | $40.00 | |
| 82947 | 23 | 14 | $14.79 | |
| 91305 | 248 | 224 | $0.00 | |
| 91301 | 18 | 17 | $0.00 | |
| 1000F | 50 | 50 | $0.00 | |
| 91315 | 31 | 31 | $0.00 | |
| 91300 | 505 | 304 | $0.00 | |
| 91312 | 237 | 209 | $0.00 | |
| 4120F | 135 | 135 | $0.00 | |
| 4124F | 330 | 325 | $0.00 | |
| 90710 | 25 | 20 | $0.00 |